tiprankstipranks
Trending News
More News >
Instil Bio, Inc. (TIL)
NASDAQ:TIL
US Market

Instil Bio (TIL) Income Statement

Compare
378 Followers

Instil Bio Income Statement

Last quarter (Q3 2025), Instil Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Instil Bio's net income was $-13.59M. See Instil Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 138.00K
Gross Profit
$ 0.00$ 0.00$ -5.99M$ 0.00$ 138.00K
Operating Expenses
$ 73.54M$ 159.17M$ 200.18M$ 155.56M$ 33.78M
Depreciation and Amortization
$ 3.61M$ 4.76M$ 5.99M$ 2.75M$ 256.00K
EBITDA
$ -62.53M$ -147.12M$ -217.38M$ -152.51M$ -33.39M
Operating Income
$ -73.54M$ -159.17M$ -206.17M$ -155.56M$ -33.64M
Other Income/Expenses
$ -594.00K$ 3.08M$ -19.08M$ -1.20M$ -3.94M
Pretax Income
$ -74.14M$ -156.09M$ -225.25M$ -156.75M$ -37.59M
Net Income
$ -74.14M$ -156.09M$ -223.18M$ -156.79M$ -37.74M
Per Share Metrics
Basic EPS
$ -11.39$ -24.00$ -34.46$ -29.60$ -5.89
Diluted EPS
$ -11.39$ -24.00$ -34.46$ -29.60$ -5.89
Weighted Average Shares Outstanding
6.51M 6.50M 6.48M 5.30M 6.41M
Weighted Average Shares Outstanding (Diluted)
6.51M 6.50M 6.48M 5.30M 6.41M
Currency in USD

Instil Bio Earnings and Revenue History